Valeant Pharmaceuticals International

Bookmark

Add to MyYahoo RSS

Valeant Pharmaceuticals International News

News on Valeant Pharmaceuticals International (Ticker: VRX) continually updated from thousands of sources around the net.

Monday Apr 7 | BioSpace

Meda AB, Valeant Pharmaceuticals International Terminate Joint Ventures

Meda And Valeant Terminates Joint Ventures GOTEBORG, Sweden-- Regulatory News: Meda has reached an agreement with Valeant to terminate the companies' joint ventures in Canada, Mexico and Australia in the second quarter of 2014.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, AB Electrolux, Appliances, Sweden, World News, Marketing

Wed Apr 02, 2014

AmericanBankingNews.com

Valeant Pharmaceuticals Intl Receives Average Recommendation of "Buy" from Brokerages

Valeant Pharmaceuticals Intl has earned an average rating of "Buy" from the nineteen analysts that are presently covering the stock, ARN reports .

Comment?

Related Topix: Biotech, Medicine, Valeant Pharmaceuticals International, Biovail, Healthcare Industry

Tue Apr 01, 2014

GuruFocus.com

Top Guru-Held Canadian Stocks

Using the GuruFocus Aggregated Portfolio Screener you can filter results to see what companies maintain the highest amount of guru ownership.

Comment?

Related Topix: Financial Markets, Biotech, Valeant Pharmaceuticals International, Mining, Potash Corporation of Saskatchewan, Chemicals

Wed Mar 26, 2014

MarketNewsVideo

Wednesday 3/26 Insider Buying Report: SANW, VRX

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Video, Business News

Minyanville

Stocks: Insiders Buy at Regeneron, Valeant, and MDC Partners

Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside purchases recently filed with the SEC.

Comment?

Related Topix: Financial Markets, 72andSunny, Commercial Printing, MDC, Marketing, Biotech, Valeant Pharmaceuticals International

Tue Mar 25, 2014

Sys-Con Media

Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%

Actavis acquired the rights to Metronidazole 1.3% from Valeant Pharmaceuticals International in Bacterial vaginosis is an infection caused by an imbalance in the normal bacteria in the vagina.

Comment?

Related Topix: Medicine, Metronidazole (generic), MetroGel, Healthcare Law, Food and Drug Administration, Law, Biotech, Valeant Pharmaceuticals International, Women's Health, Health

Fri Mar 21, 2014

Sys-Con Media

Reviewing the Top Health Care Equities -- Research on...

The gains were broad based as nine of ten sectors finished higher. The S&P 500 Health Care Sector Index finished the day 0.02% lower at 686.29, whereas, the index has advanced 0.77% in the last one month.

Comment?

Related Topix: Healthcare Industry, Biotech, Medicine, Medical Equipment, Delcath Systems, Viasys Healthcare, Alkermes, Valeant Pharmaceuticals International

Thu Mar 20, 2014

BioSpace

Valeant Pharmaceuticals International CEO Eyes Corporate "Fat" In Push For Big Leagues

After Valeant Pharmaceuticals International Inc. bought Bausch & Lomb Inc. for $8.7 billion last year, Chief Executive Officer Mike Pearson discovered the budget for the eyecare company's communications team was 13 times the size of his own.

Comment?

Related Topix: Biotech, Valeant Pharmaceuticals International, Bausch and Lomb, Medical Equipment, Medicine, Healthcare Industry

Wed Mar 19, 2014

AmericanBankingNews.com

Valeant Pharmaceuticals Intl Sees Large Drop in Short Interest

Valeant Pharmaceuticals Intl saw a significant decrease in short interest in the month of January.

Comment?

Related Topix: Biotech, Medicine, Valeant Pharmaceuticals International, Biovail, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••